HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Peters, C. Articles by Paterson, Y. Search for Related Content PubMed PubMed Citation Articles by Peters, C. Articles by Paterson, Y.

The Induction of HIV Gag-Specific CD8⁺ T Cells in the Spleen and Gut-Associated Lymphoid Tissue by Parenteral or Mucosal Immunization with Recombinant Listeria monocytogenes HIV Gag¹

Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104

The induction of mucosal immunity is crucial in controlling viral replication during HIV infection. In this study we compare the ability of a recombinant Listeria monocytogenes that expresses and secretes the HIV Ag Gag to induce CD8⁺ T cells against this Ag in the spleen, mesenteric lymph nodes, and Peyer’s patches and the ability to provide effector Gag-specific CD8⁺ T cells to the lamina propria after i.v., oral, or rectal administration of the vaccine. The levels of Ag-specific CD8⁺-activated T cells were measured ex vivo using intracellular cytokine staining for IFN- and H-2K^d Gag peptide tetramer staining. We found that all routes of immunization induced Gag-specific CD8⁺ T cells in the spleen. After secondary infection, we observed substantial increases in splenic levels of CD8⁺ T cells, and levels of Gag-specific cells were similar to those against listeriolysin O, the immunodominant Ag of L. monocytogenes. Both primary and secondary oral immunization resulted in abundant Gag-specific CD8⁺-activated T cells in the lamina propria that constituted 35% of the CD8 compartment. However, significant levels of Gag and listeriolysin O-specific CD8⁺ T cells were observed in mucosal lymphoid tissue only after two immunizations, perhaps because they had already entered the lamina propria compartment after a single immunization. In the context of HIV, a mucosally administered vaccine seems best calculated to prompt an immune response that is capable of preventing infection. The data presented in this report demonstrate that mucosally administered Listeria can prompt such a response and that booster doses can maintain this response.

This article has been cited by other articles:

				B. del Rio, R. J. Dattwyler, M. Aroso, V. Neves, L. Meirelles, J. F. M. L. Seegers, and M. Gomes-Solecki Oral Immunization with Recombinant Lactobacillus plantarum Induces a Protective Immune Response in Mice with Lyme Disease Clin. Vaccine Immunol., September 1, 2008; 15(9): 1429 - 1435. [Abstract] [Full Text] [PDF]

				P. Lauer, B. Hanson, E. E. Lemmens, W. Liu, W. S. Luckett, M. L. Leong, H. E. Allen, J. Skoble, K. S. Bahjat, N. E. Freitag, et al. Constitutive Activation of the PrfA Regulon Enhances the Potency of Vaccines Based on Live-Attenuated and Killed but Metabolically Active Listeria monocytogenes Strains Infect. Immun., August 1, 2008; 76(8): 3742 - 3753. [Abstract] [Full Text] [PDF]

				J. M. Thompson, M. G. Nicholson, A. C. Whitmore, M. Zamora, A. West, A. Iwasaki, H. F. Staats, and R. E. Johnston Nonmucosal Alphavirus Vaccination Stimulates a Mucosal Inductive Environment in the Peripheral Draining Lymph Node J. Immunol., July 1, 2008; 181(1): 574 - 585. [Abstract] [Full Text] [PDF]

				X. Zhao, M. Zhang, Z. Li, and F. R. Frankel Vaginal Protection and Immunity after Oral Immunization of Mice with a Novel Vaccine Strain of Listeria monocytogenes Expressing Human Immunodeficiency Virus Type 1 gag. J. Virol., September 1, 2006; 80(18): 8880 - 8890. [Abstract] [Full Text] [PDF]

				G. W. Stone, S. Barzee, V. Snarsky, K. Kee, C. A. Spina, X.-F. Yu, and R. S. Kornbluth Multimeric Soluble CD40 Ligand and GITR Ligand as Adjuvants for Human Immunodeficiency Virus DNA Vaccines J. Virol., February 15, 2006; 80(4): 1762 - 1772. [Abstract] [Full Text] [PDF]

				X. Chen, M. T. Rock, J. Hammonds, J. Tartaglia, A. Shintani, J. Currier, B. Slike, J. E. Crowe Jr., M. Marovich, and P. Spearman Pseudovirion Particle Production by Live Poxvirus Human Immunodeficiency Virus Vaccine Vector Enhances Humoral and Cellular Immune Responses J. Virol., May 1, 2005; 79(9): 5537 - 5547. [Abstract] [Full Text] [PDF]

				C. N. Kotton and E. L. Hohmann Enteric Pathogens as Vaccine Vectors for Foreign Antigen Delivery Infect. Immun., October 1, 2004; 72(10): 5535 - 5547. [Full Text] [PDF]

				R. Stevens, K. E. Howard, S. Nordone, M. Burkhard, and G. A. Dean Oral Immunization with Recombinant Listeria monocytogenes Controls Virus Load after Vaginal Challenge with Feline Immunodeficiency Virus J. Virol., August 1, 2004; 78(15): 8210 - 8218. [Abstract] [Full Text] [PDF]